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Available online 19 December 2015AbstractMembrane cholesterol plays an important role in modulating the function of several membrane proteins. From these proteins, a
special cholesterol binding motif is reported to which the membrane cholesterol binds and modulates their activity. This consensus
motif is either seen as a forward pattern known as CRAC (L/V-X(1-5)-Y-X(1-5)-R/K) and/or as a backward pattern CARC (R/K-X(1-
5)-Y-X(1-5)-L/V). This as such is a low consensus motif as substituting amino acid in the unconserved positions of the motif (‘X’)
yields many combinations. In order to obtain a better consensus motif for cholesterol binding, it is worthwhile to look for the same
within a membrane proteins superfamily (ABC transporters, GPCRs, etc.) and assign them as a signature motif. Therefore, in the
current work an attempt was made to identify the distribution of this motif in all seven helices of GPCR family and assign a
consensus signature motif for an individual helix using a novel Fuzzy C-Means (FCM) approach. The workflow proceeds in four
phases; first, GPCR protein sequences were extracted from UniProt database that contains seven transmembrane (TM) helices and a
cholesterol dictionary has been designed for different window sizes. In second phase; those sequences are filtered which starts with
R/K or L/Vusing both CRAC and CARC cholesterol recognition methods leading to discovery of filtered cholesterol motifs. Third
phase leads to identification of significant cholesterol motifs using FCM algorithm by computing the membership of sequences to
different motifs and pattern matching with different helices. Finally those uncovered cholesterol motifs that matched with TM
helices were analyzed. From the results we report an algorithm that can efficiently identify and assign cholesterol signature motifs
in GPCR protein sequences that can be further extended to other membrane proteins.
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Membrane cholesterol is small and amphipathic
molecule that is distributed heterogeneously on either
sides of the membrane bilayer with its polar hydroxyl
group facing the extracellular or intracellular space. In
mammalian cells, cholesterol is a very essential steroln behalf of University of Kerbala. This is an open access article under
4.0/).
213R. Tripathy et al. / Karbala International Journal of Modern Science 1 (2015) 212e224that is required for cell development and differentiation
[1e5]. The plasma membrane harbors several families
of transmembrane proteins (TMP) such as G-protein
coupled receptors (GPCR) or ion channels for
signaling or transport of molecules across the mem-
brane from the external environment for intracellular
activities [1,2,6e9]. TMPs are either 20e30 residue
long amphipathic alpha-helices or pore forming beta-
barrels that span across the membrane [3,10,11].
These TMPs cluster as domains in the bilayer that are
enriched in cholesterol [12]. Several reports show that
the localization of TMP in these domains is important
for the modulation and regulation of associated pro-
teins. From a sequence analysis on a membrane pe-
ripheral benzodiazepine receptor, a low-consensus
cholesterol binding motif was identified and referred to
as CRAC motif (L/V-X(1-5)-Y-X(1-5)-R/K) that was first
proposed to be a binding site for membrane cholesterol
[13e15]. Later, CARC motif was also reported that
was seen as a reverse of CRAC motif (R/K-X (1-5)-Y-X
(1-5)-L/V) [15]. The CRAC or CARC motifs are present
in different parts of the membrane protein helix
depending on the presence of cholesterol in different
layers and its orientations [1,16]. Recent reports also
show that CRAC motifs are present in envelop proteins
of viruses such as HIV, Influenza, etc., and help in their
entry [17,18]. Among the membrane proteins, GPCRs
are reported to be modulated by membrane cholesterol
by interacting with these CRAC or CARC motifs
present in the TM helices [17]. This is a large super
family with more than 800 proteins that is evolution-
arily conserved and share same topology comprising of
seven hydrophobic transmembrane segments [16].
GPCRs play a very important role in cell signaling and
homeostasis and therefore, precisely defining and
assigning a signature cholesterol binding motifs has a
great clinical implication [18e20].
In current research, many data mining algorithms
have been applied in several problems in bioinfor-
matics. A technique commonly employed in classifi-
cation is Support Vector Machine (SVM) which has
also been utilized in GPCR classification [21]. An
interesting problem is the prediction of cholesterol
motif with GPCRTM. Many of the researchers have
investigated varieties of classifiers like SVM, Naïve
Bayesian, and Neural Network etc. to predict the
cholesterol motif [14,22]. In GPCR family of proteins,
each helical structure have different sequence files and
every time cholesterol dictionary match with TM he-
lices, leads to a computational burden on the algo-
rithms, for which many research has been carried out
based on data mining algorithms. Nearly half of thehuman genome consists of repeated-sequence elements
and identifying and characterizing such repeated ele-
ments is essential for understanding diseases at the
molecular level. Victor X. Jin et al. [23] proposed a
model to find the localized interspersed motifs and
presented a computational approach for detecting those
repeated sequences. They have used all-pairs enumer-
ation, clustering and filtering, matching and ranking
methods. Many simple pattern matching algorithms
along with statistical measures have been used to
identify the cholesterol motifs. Those methods have
significant problem associated with computational is-
sues such as; processing time to match each helix with
cholesterol motifs which burden the system [19,24,25].
To address this computational burden, data mining
based methods such as clustering and classification
techniques have been proposed for motif finding. In the
current work, a Fuzzy C-Means (FCM) based
computing method has been adopted for generation of
possible motifs, large datasets of protein sequence,
pattern matching in different helices and reporting
[26e30]. Therefore, the focal point of our current work
is to identify signature motifs that comply with the
cholesterol binding motifs in GPCRs and report on
their type and occurrence. The layout of the papers is
as follows: in section 2; the proposed FCM based
cholesterol motif finding methodology is explained and
the experimental evaluation with example is illustrated
followed by a conclusion derived from the work in
section 3.
2. Methodology and experimental evaluation
The protein sequence and trans-membrane infor-
mation was retrieved from UniProt database [29]. The
datasets were downloaded and retrieved into respective
helical H1 to helical H7 files in text (.txt) format. Each
helical file contains of 820 protein sequences. The
major objective of current work is to identify and fetch
the entire cholesterol consensus motif available in the
protein primary sequences and develop a signature
motif for receptors belonging to GPCR superfamily. As
such the different possibilities of the CRAC or CARC
motifs are signature cholesterol motifs are listed in
Table 1. From Table 1; X (1-5) signifies that “X” can be
a combination of any aminoacid length ranging 1 to 5.
Considering the signature of cholesterol motif and
fixing the three residues at beginning (L/V or R/K),
middle (Y), and last position (R/K or L/V), the length
should be of length ranging from 5 (as minimum) to 13
(as maximum) for CRAC and CARC pattern recogni-
tion methods. In this paper, steps have been taken to
Table 1
Cholesterol backward and forward sequences where X ¼ {set of 20 amino acid residues}.
Motif type FORWARD (CRAC)
(L/V-X(1-5)-Y-X(1-5)-R/K)
BACKWARD (CARC)
(R/K-X(1-5)-Y-X(1-5)-L/V)
L ¼ length of
cholesterol motif
11 L/V-X-Y-X-K/R K/R-X-Y-X-L/V 5
12 L/V-X-Y-XX-K/R K/R-X-Y-XX-L/V 6
13 L/V-X-Y-XXX-K/R K/R-X-Y-XXX-L/V 7
14 L/V-X-Y-XXXX-K/R K/R-X-Y-XXXX-L/V 8
15 L/V-X-Y-XXXXX-K/R K/R-X-Y-XXXXX-L/V 9
21 L/V-XX-Y-X-K/R K/R-XX-Y-X-L/V 6
22 L/V-XX-Y-XX-K/R K/R-XX-Y-XX-L/V 7
23 L/V-XX-Y-XXX-K/R K/R-XX-Y-XXX-L/V 8
24 L/V-XX-Y-XXXX-K/R K/R-XX-Y-XXXX-L/V 9
25 L/V-XX-Y-XXXXX-K/R K/R-XX-Y-XXXXX-L/V 10
31 L/V-XXX-Y-X-K/R K/R-XXX-Y-X-L/V 7
32 L/V-XXX-Y-XX-K/R K/R-XXX-Y-XX-L/V 8
33 L/V-XXX-Y-XXX-K/R K/R-XXX-Y-XXX-L/V 9
34 L/V-XXX-Y-XXXX-K/R K/R-XXX-Y-XXXX-L/V 10
35 L/V-XXX-Y-XXXXX-K/R K/R-XXX-Y-XXXXX-L/V 11
41 L/V-XXXX-Y-X-K/R K/R-XXXX-Y-X-L/V 8
42 L/V-XXXX-Y-XX-K/R K/R-XXXX-Y-XX-L/V 9
43 L/V-XXXX-Y-XXX-K/R K/R-XXXX-Y-XXX-L/V 10
44 L/V-XXXX-Y-XXXX-K/R K/R-XXXX-Y-XXXX-L/V 11
45 L/V-XXXX-Y-XXXXX-K/R K/R-XXXX-Y-XXXXX-L/V 12
51 L/V-XXXXX-Y-X-K/R K/R-XXXXX-Y-X-L/V 9
52 L/V-XXXXX-Y-XX-K/R K/R-XXXXX-Y-XX-L/V 10
53 L/V-XXXXX-Y-XXX-K/R K/R-XXXXX-Y-XXX-L/V 11
54 L/V-XXXXX-Y-XXXX-K/R K/R-XXXXX-Y-XXXX-L/V 12
55 L/V-XXXXX-Y-XXXXX-K/R K/R-XXXXX-Y-XXXXX-L/V 13
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H7 data files and to design a dictionary
D ¼ fd5; d6; d7; d8; d9;d10; d11; d12; d13g n!r!ðnrÞ! of
cholesterol motifs having attributes a ¼ [Motif, helical
id, protein id, start position, end position] where,
di2dictionary of length i. From Table 1 it can be un-
derstood that cholesterol motif sequence for any length
L > 5 multiple motif types and accordingly motif
signatures can be extracted by using both CRAC and
CARC methods. For example, considering d8, having
length L¼ 8 can have motif types MT ¼ {14, 23, 32,DLi ¼
Motif length
No:of Sequence
¼

5
179586
;
6
173872
;
7
168158
;
8
162444
;
9
156731
;
10
151018
;
11
145305
;
12
139592
;
13
133880

ci2L
ð1Þ41} and cholesterol motif signatures can be in the form
of L/V X Y XXXXK/R, L/V XX Y XXXK/R, L/V
XXX Y XXK/R, L/V XXXX Y XK/R and K/R X Y
XXXXL/V, K/R XX Y XXXL/V, K/R XXX Y XXL/V
and K/R XXXX Y XL/V for the sequences uncovered
using both CRAC and CARC methods respectively.Where, X can be any residue from a set of 20 amino
acid residues. Here, it can be noticed that length re-
mains constant but cholesterol signature motifs differs
only in the position with respect to ‘Y’, beginning
residue and ending residue.
Fig. 2 is a schematic layout of the model that de-
scribes storing of helical files H1eH7 in text format
which is read sequentially one by one and whose data
are extracted one at a time using sliding window
technique for the length L¼{5, 6, 7, 8, 9, 10, 11, 12,
13}. Dictionary DLi can be formulated using (1) Fig. 1.Rule based filtration is used with the dataset for
finding the sub-sequences for using both CRAC and
CARC. This process helps to reduce the dimension of
the data by filtering only valid signature sequences.
Filtration is done in three phases; in phase 1, only those
data which starts with R/K or L/V for forward and
Fig. 1. The 7 helices with N-terminus and C-terminus.
Fig. 2. Schematic layout of cholesterol common signature identification model.
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filtered, in phase 2; data obtained from the phase 1 that
ends with L/V or R/K for forward and backward
searching mechanism for cholesterol sequences
respectively are passed and finally in phase 3; the data
containing ‘Y’ in between the result obtained in phase
2 are filtered. After passing through these three phases,
the dimension of the dictionary is marginally reduced
leading to improve the computational efficiency of our
proposed cholesterol motif finding model. The process
of cholesterol signature motif finding is illustrated in
Figs. 3 and 4 using both CRAC and CARC recognition
methods.
The total sub-sequences (signature motifs) uncov-
ered after the filtration process is 1912 and 3918 forusing CRAC and CARC recognition method respec-
tively and shown in Tables 2 and 3. It is noticeable that,
the backward sequence combination {R-X(1-5)-Y-X(1-
5)-L, K-X(1-5)-Y-X(1-5)-L, R-X(1-5)-Y-X(1-5)-V, K-X(1-5)-
Y-X(1-5)-V} are found to be 745, 504, 304 and 359 for
different motif types. Similarly, for CRAC combina-
tion {L-X(1-5)-Y-X(1-5)-R, L-X(1-5)-Y-X(1-5)-K, V-X(1-5)-
Y-X(1-5)-R, V-X(1-5)-Y-X(1-5)-K} are found to be 1774,
956, 759 and 429 for different motif types. The par-
ticulars of the motif information are provided as
supplementary files in separate MSeEXCEL file
named as ALL_Back.xlsx and ALL_For.xlsx for
reference.
The objective of this paper is to find most significant
motifs signatures using both CARC and CRAC motif
Fig. 3. Forward search of cholesterol signature (CRAC).
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number of available motif sequences, a better data
mining method for finding most significant motif
structures is required. For example; a given motif:
RRYSYYYL of length 8 can belong to more than onemotif types such as 14, 32 and 41 as given in Table 1.
Therefore, to mine such kinds information where data
can belong to more than one cluster, FCM algorithm
[30,31] is used in this proposed work. The FCM as-
signs each data point to one or more cluster centers on
Fig. 4. Backward search of cholesterol signature (CARC).
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points. The algorithm is based on minimization of the
following objective function (2):Clusterk ¼
XNo: of motifs
i¼1
XNo: of centers
j¼1 membership
k
i j
k motifi  centerjk2;1 k ∞ ð2Þ
Table 2
Forward cholesterol sequences observed in GPCRs for different Motif Types (MT) matching CRAC.
lT-Length L-X(1-5)-Y-X(1-5)-R L-X(1-5)-Y-X(1-5)-K V-X(1-5)-Y-X(1-5)-R V-X(1-5)-Y-X(1-5)-K Total
5 44 23 31 13 111
6 249 49 177 27 502
7 74 41 94 41 250
8 377 219 99 93 788
9 629 112 146 89 976
10 191 68 88 60 407
11 125 297 56 46 524
12 61 122 60 54 297
13 24 25 8 6 63
Total 1774 956 759 429 3918
Table 3
Backward cholesterol sequences observed in GPCRs for different Motif Types (MT) matching CARC.
lT-Length R- X(1-5)-Y- X(1-5)-L K- X(1-5)-Y- X(1-5)-L R- X(1-5)-Y- X(1-5)-V K- X(1-5)-Y- X(1-5)-V Total
5 24 20 19 8 71
6 51 32 36 26 145
7 79 51 32 21 183
8 102 52 43 23 220
9 123 84 67 109 383
10 159 107 51 98 415
11 70 62 26 28 186
12 34 25 13 23 95
13 103 71 17 23 214
Total 745 504 304 359 1912
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XN
i¼1
XC
j¼1
umij k xi  cik2;1 m∞
where, k > 1, No. of centers¼ number of clusters, association
of motifi in the jth cluster, motifi is the ith of d-dimensional
measured data, centerj is the d-dimensional center of the
cluster. Fuzzy partitioning is carried out through an iterative
optimization of the objective function shown above, with
updating the membership uij and the cluster centers cj
computed using (3). The algorithm stops when,
maxijf
membershippþ1ij  membershippij
g< ε , where ε is a
termination criterion between 0 and 1, whereas; p are theiteration steps. This procedure converges to a local minimum
or a saddle point Clusterk. The algorithm for FCM is given in
algorithm 1.
membershipij ¼ 1PNo:of Center
p¼1
kmotificenterjk
kmotificenterpk
 2
k1
ð3Þ
where, centerj is computed using (4),
centerj ¼
PNo:of Motifs
i¼1 membership
k
ij:motifiPNo:of Motifs
i¼1 membership
k
ij
ð4Þ
Fig. 5. Complete systematic flow of proposed methodology on dictionary of motif of length 8 for CRAC: R-X(1)-Y-X(4)-L, R-X(2)-Y-X(3)-L, R-
X(3)-Y-X(2)-L, R-X(4)-Y-X(1)-L.
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of clusters with similar signatures that help to calculate
the weight of individual residue with respect to their
position. For example; considering Fig. 5, where d8
dictionary has been used to uncover the most signifi-
cant motif signatures using both CRAC and CARC
RX(1)YX(4)L, RX(2)YX(3)L, RX(3)YX(2)L, RX(4)YX(1)L. The better resolution image is provided in
supplementary material for a better view (Flow.jpg).
The Fig. 5 represents the necessary steps to illustrates
the working procedure of signature sequence discovery
of length 8 using CRAC (backward) as an example to
make it clear for the readers to understand themechanism
of uncovering cholesterol signature motifs.
Table 4a
Forward Signature Motifs for GPCRs derived from L/V-X (1-5)-Y-X (1-5)-R/K.
CRAC motif type (forward) Helix Signature Protein name
V-XXXX-Y-XXX-K V4Y3K H2 L(H,Q) (T) (P) (M)Y(F) (F,L) (L)R Olfactory receptor(24)
L-XX-Y-X-R L2Y1R H3 L(M,F,V) (S,M)Y(D,A,I,L)R Olfactory receptor(13)
Histamine H3 receptor(1)
Histamine H4 receptor(1)
L-XXXX-Y-X-R L4Y1R H3 L(A) (A,V) (M) (A)Y(D)R Olfactory receptor(113)
L-XXXXX-Y-X-R L5Y1R H3 L(L) (A) (A,V) (M) (A)Y(D)R Olfactory receptor(95)
L-XXX-Y-XX-K L3Y2K H3 L(S,G) (I) (F,L)Y(L,C,F) (L)K Taste receptor(10)
V-XX-Y-X-R V2Y1R H3 V(M) (A)Y(D)R Olfactory receptor(67)
Opsin-3(1)
V-XXX-Y-X-R V3Y1R H3 V(L,V,S,M) (M) (A,S)Y(D)R Olfactory receptor(15)
Histamine H3 receptor(1)
Histamine H4 receptor(1)
L-X-Y-X L1Y1R H5 V(I)Y(L,N,T)K Olfactory receptor(5)
L-XX-Y-X L2Y1R H5 L(M,F,V) (S,M)Y(D,A,I,L)R Olfactory receptor(15)
5-hydroxytryptamine receptor(2)
G-protein coupled receptor(1)
L-X-Y-XXXX-R L1Y4R H5 L(S)Y(S,T,A,L) (L,Y,R) (I) (N,L,I)R Olfactory receptor(9)
G-protein coupled receptor(1)
Galanin receptor(1)
Prokineticin receptor(2)
L-XXXX-Y-XXXX-R L4Y4R H5 L(N,I) (P,L) (F,L,V) (I,S)Y(S,T)
(L) (R,I) (N)R
Olfactory receptor(10)
D(4) dopamine receptor(2)
Neuropeptide FF receptor(1)
Ovarian cancer G-protein
coupled receptor(1)
Probable G-protein coupled
receptor(1)
Thyrotropin-releasing hormone
receptor(1),
Urotensin-2 receptor(1)
L-XXXXX-Y-XXXX-K L5Y4K H5 L(L) (N) (P) (I,F,V,L) (I)Y(S,T) (L) (R) (N)K CeC chemokine receptor(2)
P2Y purinoceptor(2)
V-XXXX-Y-XXXX-K V4Y4K H5 V(N) (P) (I,L) (I,V)Y(S,G,T) (L) (R,I,K) (N)K CeC chemokine receptor(4)
L-XX-Y-X-R L2Y1R H6 L(M,F,V) (S,M)Y(D,A,I,L)R Olfactory receptor(15)
L-XXX-Y-R L3Y1R H6 L(I,L,F,V) (F) (M)Y(L,V,G,S)R Olfactory receptor(15)
V-X-Y-X-K V1Y1K H6 V(I)Y(L,N,T)K Olfactory receptor(5)
V-XXXXX-Y-X-R V5Y1R H6 V(P) (C) (I,V) (F,Y,I) (V,I,A,L)Y(A,L)R Olfactory receptor(16)
Frizzled-10(1)
Relaxin receptor(1)
L-X-Y-XX-R L1Y2R H7 L(I)Y(S) (L)R Olfactory receptor(123)
L-X-Y-XXXX-R L1Y4R H7 L(S)Y(S,T,A,L) (L,Y,R) (I) (N,L,I)R Olfactory receptor (6)
Probable G-protein coupled
receptor(1)
L-XXXX-Y-XX-R L4Y2R H7 L(N) (P) (L) (I)Y(S) (L)R Olfactory receptor(227)
L-XXXXX-XX-R L5Y2R H7 L(L) (N) (P) (F,I,L,V) (I)Y(T,S) (L)R Olfactory receptor(58)
L-XXXX-Y-XXXX-R L4Y4R H7 L(N,I) (P,L) (F,L,V) (I,S)Y(S,T) (L) (R,I) (N)R Olfactory receptor(20)
Sphingosine 1-phosphate receptor(1)
G-protein coupled receptor(1)
L-X-Y-XX-K L1Y2K H7 L(I)Y(T,S) (L,V)K Olfactory receptor(7)
L-X-Y-XXXX-K L1Y4K H7 L(I)Y(S) (L) (R) (N)K Olfactory receptor(92)
L-XXX-Y-XX-K L3Y2K H7 L(S,G) (I) (F,L)Y(L,C,F) (L)K Metabotropic glutamate receptor(3)
L-XXXX-Y-XX-K L4Y2K H7 L(N) (P) (L,I) (I,V)Y(G,S) (L,V)K Olfactory receptor(12)
L-XXXX-Y-XXXX-R L4Y4K H7 L(N) (P) (L,I) (I)Y(S) (L) (R) (N)K Olfactory receptor(168)
G-protein coupled receptor(2)
N-arachidonyl glycine receptor (1)
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Table 4a (continued )
CRAC motif type (forward) Helix Signature Protein name
L-XXXX-Y-XXXXX-K L4Y5K H7 L(N) (P) (I,L,V) (I,L)Y(A,T,F) (L,F)
(R,I,L) (N,G) (K,E)K
Olfactory receptor(3)
C-X-C chemokine receptor(3)
G-protein coupled receptor(2)
C-C chemokine receptor(1, C-X-C
chemokine receptor(1)
CX3C chemokine receptor(1)
Leucine-rich repeat-containing
G-protein coupled receptor(1)
L-XXXXX-Y-XXXX-K L5Y4K H7 L(L) (N) (P) (I,F,V,L) (I)Y(S,T) (L) (R) (N)K Olfactory receptor(42)
V-X-Y-XX-R V1Y2R H7 V(I,V)Y(S,T) (L)R Olfactory receptor(13)
V-XXXX-Y-XX-R V4Y2R H7 V(N) (P) (I,L) (I)Y(S,A) (L)R Olfactory receptor(6)
Adenosine receptor(2)
Sphingosine 1-phosphate receptor(1)
V-XXXXX-Y-XX-R
V5Y2R
H7 V(L) (N) (P) (L) (I)Y(S) (L)R Olfactory receptor(18)
V-X-Y-XXXX-K V1Y4K H7 V(I,V)Y(T,S) (L) (R) (N)K Olfactory receptor(18)
V-XXXX-Y-XXXX-K V4Y4K H7 V(N) (P) (I,L) (I,V)Y(S,G,T) (L) (R,I,K) (N)K Olfactory receptor(12)
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sequences.
Step 2: During the succeeding phases of filtration
process the size shrinks. In phase 1, total 3558 se-
quences were filtered which starts with residue ‘R’.
Step 3: In phase 2, motif that starts with residue ‘L’
is selected from phase 1. The total data now is reduced
to 638 number of motif sequences.
Step 4: In Phase 3, only those motifs are filtered
which contains residue ‘Y’ at intermediate position of
638 sequences available after phase 2. The valid po-
sition for ‘Y’ is 3, 4, 5 and 6 depending on the type of
motif before mining. The valid motif type can be 14,
23, 32 and 41 depending on the size of cholesterol
motif of window i.e., 8. For 3rd and 4th position of ‘Y’
we get 19 cholesterol sequences, 5th position of ‘Y’ we
get 33 cholesterol sequences and 6th position we get 31
cholesterol sequences.
Step 5: Now, this information is passed to FCM to
form clusters of similar patterns of motif. For every set
of motif pairs on different position of ‘Y’ we get 10,
10, 11, 10 number of clusters. The motifs belonging to
individual cluster are sorted and the number of times a
particular residue is present in particular position is
calculated and stored as weight.
Step 6: (Discovering most significant motifs) For
motif type 14, we need to look for the residue majorly
present in position 1 before ‘Y’ and look for the resi-
dues after ‘Y’ majorly present in position 1e4. It can
be seen that, ‘N’ is present 4 and 3 times at position 1
before ‘Y’ in cluster 9 and 6. R(N)Y(I,V) (H) (M)
(H,N)L with weight (4)j(4,3) (4) (4) (4,3). Similarly
R(A,V) (C,P,S,I)Y(A,Y,T) (L,S,I,M,T) (L,V)L withweight (3,2) (2,2,2,1)j(2,2,1) (2,2,1,1,1) (2,1), R(E)
(L,P) (C,M,S)Y(I,F) (L)L with weight (4) (4,4)
(4,4,4)j(5,4) (4), R(V,T) (N,P) (L,T,V,A,I,K,N,P,R,S)
(I,Y,N,V)Y(G,L)L with weight (3,2) (3,2)
(2,2,2,1,1,1,1,1,1,1) (3,3,2,2)j(3,2) is uncovered as
most significant cholesterol motif signatures for motif
type 23, 32 and 41 respectively.
Applying the FCM algorithm to identify motifs in
GPCRs resulted in significantly more number of forward
motif (CRAC) than the backward motif (CARC). Tables
4a and 4b is a summary of significant cholesterol signa-
tures motifs (CRAC and CARC) identified using the FCM
algorithm with details regarding the motif type (Column
#1), helix observed (Column #2), a profile of the sub-
stitutions observed in the motif (Column #3) and the
protein where the given motif was observed (Column #4).
From the table it is inferred that the type of motifs (Col-
umn #1) are restricted and vary depending on the helix.
CRAC motifs were seen in H2, H3, H5, H6 and H7 while
CARCs were seen only in H2 and H7 complying with the
unevenly distributed cholesterol in the membrane leaflets.
Further the choice for amino acid substitution for X show
that these amino acids are highly conserved for a given
family or a subfamily (Column #3). The results obtained
clearly show that the combinations from CRAC or CARC
is indeed restricted to a family that can be further devel-
oped as a signature motif based on the family, helix or the
location in the membrane leaflet.
3. Conclusion
Modulation of membrane proteins by cholesterol and
the cholesterol binding motif has indeed given a new
Table 4b
Backward Signature Motifs for GPCRs derived from K/R-X(1-5)-Y-X(1-5)-L/V.
CARC motif type (backward) Helix Signature Protein name
R-XX-Y-XX-L R2Y2L H2 R(P) (M,L)Y(F,Y) (F,L)L Olfactory receptor(9)
R-XXXXX-Y-X-L R5Y1L H2 R(L) (H) (T) (P) (M)Y(F,L)L Olfactory receptor(22)
CeC chemokine receptor(3)
Mas-related G-protein
coupled receptor(2)
R-XXXXX-Y-XX-L R5Y2L H2 R(L) (H) (T) (P) (M)Y(F) (F)L Olfactory receptor(45)
R-XXXX-Y-XXX-XL R4Y4L H2 R(T) (V,P,R) (T,S) (N)Y(F) (I,L) (V,L) (N,L)L Orexin receptor(2)
5-hydroxytryptamine receptor(1)
Alpha-1B adrenergic receptor(1)
Histamine H4 receptor(1)
Neuromedin-K receptor(1)
Substance-K receptor(1)
Substance-P receptor(1)
R-XXXXX-Y-XXXXX-R R5Y5L H2 R(L) (H) (T) (P) (M)Y(F) (F) (L) (S) (N,H)L Olfactory receptor(72)
R-XXXX-Y-XX-V R4Y2V H2 R(T,Q) (V,P) (T,V) (N)Y(F) (I,L)V Orexin receptor(2)
5-hydroxytryptamine receptor(1)
Alpha-1B adrenergic receptor(1)
Neuromedin-K receptor(1)
Short-wave-sensitive opsin(1)
Substance-K receptor(1)
Substance-P receptor(1)
K-XX-Y-X-XL K2Y2L H2 K(P) (M)Y(F,Y,I) (F)L Olfactory receptor(9)
K-XXX-Y-X-L K3Y1L H2 K(P,A) (M,I) (Y,M,V,S)Y(F)L Olfactory receptor(4)
Probable G-protein coupled
receptor(1)
K-XXXXX-Y-X-L K5Y1L H2 K(M,T,V,L) (A,V,I,L,M) (S,T) (V,L,N,D)
(F,I)Y(T,S,L)L
Olfactory receptor(16)
Proteinase-activated receptor(1)
K-XX-Y-XXXXX-L K2Y5L H2 K(P) (M)Y(F,Y) (F) (L) (S,A,L) (M,N)L Olfactory receptor(8)
Cannabinoid receptor(1)
Probable G-protein
coupled receptor(1)
K-XXXXX-Y-XX-L K5Y2L H2 K(L,V) (H,L,V) (T,A,S) (P,V) (M,F)Y(F,T) (F,I)L Olfactory receptor(13)
K-XXXXX-Y-XXX-L K5Y3L H2 K(T) (A,P,V,L,M) (T,S)
(N,D,V) (I)Y(I,L,T) (L) (N)L
Somatostatin receptor(4)
CeC chemokine receptor(3)
CX3C chemokine receptor(1)
Delta-type opioid receptor(1)
G-protein coupled receptor(1)
Kappa-type opioid receptor(1)
Mas-related G-protein coupled
receptor(1)
Melanin-concentrating hormone
receptor(1)
Nociceptin receptor(1)
5-hydroxytryptamine receptor(1)
Proteinase-activated receptor(1)
Type-2 angiotensin II receptor(1)
K-XXXXX-Y-XXXXX-L K5Y5L H2 K(L,V) (H,L,V) (T,A,S) (P,V,L) (M,F)Y(F,T)
(F,V) (L,I) (T) (P)L
Olfactory receptor(21)
K-XXXXX-Y-X-V K5Y1V H7 K(V,F,I,L) (A,V,I,L) (S) (V,L) (F)Y(T)V Olfactory receptor(38)
K-XXXXX-Y-XX-V K5Y2V H7 K(V,M) (A,I,V) (S) (V,L) (F)Y(T) (V)V Olfactory receptor(33)
K-XXXXX-Y-X-L K5Y1L H7 K(M,T,V,L) (A,V,I,L,M) (S,T) (V,L,N,D)
(F,I)Y(T,S,L)L
Olfactory receptor(16)
Proteinase-activated receptor(1)
K-XXXXX-Y-XX-L K5Y2L H7 K(L,V) (H,L,V) (T,A,S) (P,V) (M,F)Y(F,T) (F,I)L Olfactory receptor(13)
K-XXXXX-Y-XXXXX-I K5Y5L H7 K(L,V) (H,L,V) (T,A,S) (P,V,L) (M,F)Y(F,T)
(F,V) (L,I) (T) (P)L
Olfactory receptor(21)
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just being a cell barrier. Mutations in the residues of the
cholesterol binding motif have shown to be involved in
different pathological condition. As previouslymentioned
the CRAC motif is well-validated for cholesterol binding
but has a low consensus. Deriving a protein superfamily
specific motif will help better understand the dynamics of
the membrane cholesterol interaction with the receptor. It
is observed that there is no limit to the number of binding
motifs that can be present in any of the seven TM helix
indicating that any number of cholesterol can bind to the
receptor. The more the number of motif, the more mem-
brane cholesterolhasamodulatory role on them.Targeting
suchmotif is an important step in developing drugs against
cholesterol related disorders. In the current work, we have
adopted a data miming approach where we derived
signature motifs for families within GPCR by applying a
novel FCM methodology. Following the computational
approach, we observe that some subfamilies have a pref-
erence for forwardmotif, some for reverse and some both.
We were also able to predict the number of motifs that a
given GPCR can have and the opoid receptor, adrenergic
receptor, dopamine receptor, olfactory receptor, etc.which
were previously reported to have interaction with choles-
terol were also identified from our approach. Distribution
of CRAC and CARC were observed on both ends of the
helix indicating the orientation at which the cholesterol
might be present for interaction with membrane choles-
terol. There was consensus within proteins of a subfamily
that can be regarded as its signature motif. Understanding
it at a superfamily/family/subfamily level can help derive
and annotate a specific signature sequence for the same.
Recent reports show that the envelop proteins of several
viruses contain this cholesterol binding CRACmotif with
which they interact with the host cell, change it confor-
mation likeadaggerandenter thecells.Here, it is proposed
that by identifying such cholesterol binding motif in the
sequences,onecandesigncounteractingpeptides such that
the viral entry can be blocked. From the current work, we
conclude that the proposed FCM based algorithm is also
able to predict the CRAC and CARC sequences with high
reliability and such an algorithmwould be of great help in
developing signature cholesterol binding for individual
membrane proteins or families that might have great im-
plications in molecular targeting and medicine.Appendix A. Supplementary data
Supplementary data related to this article can be
found at doi:10.1016/j.kijoms.2015.11.006.References
[1] Y.D. Paila, A. Chattopadhyay, Membrane cholesterol in the
function and organization of G-protein coupled receptors,
Subcell. Biochem. 51 (2010) 439e466.
[2] K.L. Pierce, R.T. Premont, R.J. Lefkowitz, Seven trans-
membrane receptors, Nat. Rev. Mol. Cell Biol. 3 (9) (2002)
639e650.
[3] K. Simons, D. Toomre, Lipid rafts and signal transduction, Nat.
Rev. Mol. Cell Biol. 1 (2000) 31e39.
[4] O.G. Mouritsen, M.J. Zuckermann, What's so special about
cholesterol? Lipids 39 (2004) 1101e1113.
[5] Y. Zhang, M.E. Devries, J. Skolnick, Structure modeling of all
identified G protein-coupled receptors in the human genome,
PLoS Comput. Biol. 2 (2) (2006) article e13.
[6] Y. Lange, B. Ramos, Analysis of the distribution of cholesterol
in the intact cell, J. Biol. Chem. 258 (1983) 15130e15134.
[7] K. Burger, G. Gimpl, F. Fahrenholz, Regulation of receptor func-
tion by cholesterol, Cell. Mol. Life Sci. 57 (2000) 1577e1592.
[8] D. Lingwood, K. Simons, Lipid rafts as a membrane-organizing
principle, Science 327 (2010) 46e50.
[9] A. Fargin, J.R. Raymond, M.J. Lohse, B.K. Kobilka,
M.G. Caron, R.J. Lefkowitz, The genomic clone G-21 which
resembles a b-adrenergic receptor sequence encodes the 5-
HT1A receptor, Nature 335 (1988) 358e360.
[10] L. Anson, Membrane protein biophysics, Nature 459 (7245)
(2009) article 343.
[11] T. Sch€oneberg, M. Hofreiter, A. Schulz, H. R€ompler, Learning
from the past: evolution of GPCR functions, Trends Pharmacol.
Sci. 28 (3) (2007) 117e121.
[12] R. Fredriksson, H.B. Schi€oth, The repertoire of G-protein-
coupled receptors in fully sequenced genomes, Mol. Pharmacol.
67 (2005) 1414e1425.
[13] C. Ellis, The state of GPCR research in 2004, Nat. Rev. Drug
Discov. 3 (7) (2004) 577e626.
[14] C.J. Baier, J. Fantini, F.J. Barrantes, Disclosure of cholesterol
recognition motifs in transmembrane domains of the human
nicoticin acetylcholine receptor, Sci. Rep. 1 (2011) 69.
[15] H. Li, V. Papadopoulos, Peripheral-type benzodiazepine re-
ceptor function in cholesterol transport. Identification of a
putative cholesterol recognition/interaction amino acid
sequence and consensus pattern, Endocrinology 139 (1998)
4991e4997.
[16] S. Schlyer, R. Horuk, I want a new drug: G-protein-coupled
receptors in drug development, Drug Discov. Today 11 (11e12)
(2006) 481e493.
[17] T.J. Pucadyil, A. Chattopadhyay, Role of cholesterol in the
function and organization of G-protein coupled receptors, Prog.
Lipid Res. 45 (2006) 295e333.
[18] X. Sun, R.G. Whittaker, Role for influenza virus envelope
cholesterol in virus entry and infection, J. Virol. 77 (23) (2003)
12543e12551.
[19] R.M. Epand, A. Thomas, R. Brasseur, R.F. Epand, Cholesterol
interaction with proteins that partition into membrane domains:
an overview, Subcell. Biochem. 51 (2010) 253e278.
[20] A.K. Hamouda, D.C. Chiara, D. Sauls, J.B. Cohen,
M.P. Blanton, Cholesterol interacts with transmembrane alpha-
helices M1, M3, and M4 of the Torpedo nicotinic acetylcholine
receptor: photolabeling studies using [3H]Azicholesterol,
Biochemistry 45 (2006) 976e986.
224 R. Tripathy et al. / Karbala International Journal of Modern Science 1 (2015) 212e224[21] R. Karchin, K. Karplus, D. Haussler, Classifying G-protein
coupled receptors with support vector machines, Bioinformatics
18 (2002) 147e159.
[22] N. Cristianini, J.S. Taylor, Introduction to Support Vector Ma-
chines, Cambridge University Press, 2000.
[23] V.X. Jin, M. Turcotte, Detecting localized interspersed motifs in
genomic sequences, IEEE Trans. Instrum. Meas. 56 (5) (2007)
1770e1775.
[24] B. Ergu¨ner, O. Erdogan, U. Sezerman, Prediction and classifi-
cation of GPCR sequences based on ligand specific features,
ISCIS, LNCS 4263 (2006) 174e181.
[25] J. Corbin, H.H. Wang, M.P. Blanton, Identifying the cholesterol
binding domain in the nicotinic acetylcholine receptor with [125I]
azido-cholesterol, Biochem. Biophys. Acta 1414 (1998) 65e74.
[26] R. Nock, F. Nielsen, On weighting clustering, IEEE Trans.
Pattern Anal. Mach. Intell. 28 (8) (2006) 1e13.[27] J.C. Bezdek, Pattern Recognition with Fuzzy Objective Func-
tion Algorithms, 1981.
[28] M.N. Ahmed, S.M. Yamany, N. Mohamed, A.A. Farag,
T. Moriarty, A Modified fuzzy c-means algorithm for bias field
estimation and segmentation of MRI data, IEEE Trans. Med.
Imaging 21 (3) (2002) 193e199.
[29] UniProt Consortium, The universal protein resource (UniProt),
Nucleic Acids Res. 35 (2007) D193eD197.
[30] V. Sreenivasarao, S. Vidyavathi, Comparative analysis of
fuzzy C- mean and modified fuzzy possibilistic C
-mean algorithms in data mining, IJCST 1 (1) (2010)
104e106.
[31] P.L. Lin, P.W. Huang, C.H. Kuo, Y.H. Lai, A size-insensitive
integrity-based fuzzy c means method for data clustering,
Pattern Recognit. 47 (5) (2014) 2042e2056.
